Brett E. Houk
Impact in
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
-
- Renal cell carcinoma treatment
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 9
-
- Renal cell carcinoma treatment 9
- Lung Cancer Treatments and Mutations 6
- Advanced Breast Cancer Therapies 6
- Co-authors
- Carlo L. Bello (9 shared papers)Robert J. Motzer (5 shared papers)Bill Poland (2 shared papers)George D. Demetri (1 shared paper)Lee S. Rosen (1 shared paper)Michael Amantea (3 shared papers)Dongwoo Kang (1 shared paper)Kristen J. Pierce (9 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Clinical Cancer Research (4 papers)Cancer Chemotherapy and Pharmacology (4 papers)Cancer Research (4 papers)Clinical Pharmacokinetics (3 papers)
- Partner nations
- United StatesSpainItaly
In The Last Decade
Brett E. Houk
45 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 90
- Oncology 606
- Pulmonary and Respiratory Medicine 711
- Cancer Research 247
- Genetics 163
- Gastroenterology 77
Countries citing papers authored by Brett E. Houk
This map shows the geographic impact of Brett E. Houk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brett E. Houk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brett E. Houk more than expected).
Fields of papers citing papers by Brett E. Houk
This network shows the impact of papers produced by Brett E. Houk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brett E. Houk. The network helps show where Brett E. Houk may publish in the future.
Co-authors
The 25 scholars most cited alongside Brett E. Houk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 384 | |
| 2 | 2009 | 196 | |
| 3 | 2015 | 125 | |
| 4 | 2011 | 107 | |
| 5 | 2010 | 100 | |
| 6 | 2015 | 97 | |
| 7 | 2016 | 82 | |
| 8 | 2017 | 79 | |
| 9 | 2014 | 66 | |
| 10 | 1999 | 45 | |
| 11 | 2007 | 45 | |
| 12 | 2001 | 32 | |
| 13 | 2013 | 28 | |
| 14 | 2012 | 21 | |
| 15 | 2005 | 21 | |
| 16 | 2015 | 20 | |
| 17 | 2021 | 16 | |
| 18 | 2022 | 15 | |
| 19 | 2011 | 13 | |
| 20 | 2023 | 12 |
About Brett E. Houk
Brett E. Houk is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Genetics and Hematology, having authored 49 papers that have together received 1.6k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (9 papers), PI3K/AKT/mTOR signaling in cancer (9 papers), Chronic Lymphocytic Leukemia Research (7 papers), Cancer Treatment and Pharmacology (6 papers), Chronic Myeloid Leukemia Treatments (6 papers), Pancreatic and Hepatic Oncology Research (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Advanced Breast Cancer Therapies (6 papers). The work is most often cited by research in Oncology (606 citations), Pulmonary and Respiratory Medicine (711 citations), Cancer Research (247 citations), Genetics (163 citations) and Gastroenterology (77 citations). Brett E. Houk has collaborated with scholars based in United States, Spain and Italy. Frequent co-authors include Carlo L. Bello, Robert J. Motzer, Bill Poland, George D. Demetri, Lee S. Rosen, Michael Amantea, Dongwoo Kang, Kristen J. Pierce, Jeffrey A. Hughes and Günther Hochhaus. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Cancer Chemotherapy and Pharmacology, Cancer Research and Clinical Pharmacokinetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.